These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29195500)

  • 1. An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil.
    Kurzyna M; Małaczyńska-Rajpold K; Koteja A; Pawlak A; Chrzanowski Ł; Furdal M; Gąsior Z; Jacheć W; Sobkowicz B; Norwa J; Mularek-Kubzdela T; Torbicki A
    BMC Pulm Med; 2017 Dec; 17(1):162. PubMed ID: 29195500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable LENUS pro pump for treprostinil infusion in three pediatric patients.
    Álvarez-Fuente M; Garrido-Lestache E; Rivero N; Centella T; Lamas MJ; Pérez-Caballero C; Vázquez JL; Del Cerro MJ
    Pediatr Pulmonol; 2020 May; 55(5):1254-1258. PubMed ID: 32149476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.
    Ewert R; Richter MJ; Steringer-Mascherbauer R; Grünig E; Lange TJ; Opitz CF; Warnke C; Ghofrani HA
    Clin Res Cardiol; 2017 Oct; 106(10):776-783. PubMed ID: 28429083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Bourge RC; Waxman AB; Gomberg-Maitland M; Shapiro SM; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Torres F; Cerkvenik J; Morris M; Thalin M; Peterson L; Rubin LJ
    Chest; 2016 Jul; 150(1):27-34. PubMed ID: 27396777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1.
    Frantz RP; McDevitt S; Walker S
    J Heart Lung Transplant; 2012 Aug; 31(8):811-6. PubMed ID: 22759797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.
    Richter MJ; Harutyunova S; Bollmann T; Classen S; Gall H; Gerhardt Md F; Grimminger F; Grimminger J; Grünig E; Guth S; Halank M; Heine A; Hoeper MM; Klose H; Lange TJ; Meyer K; Neurohr C; Nickolaus K; Olsson KM; Opitz CF; Rosenkranz S; Seyfarth HJ; Warnke C; Wiedenroth C; Ghofrani HA; Ewert R
    J Heart Lung Transplant; 2018 Oct; 37(10):1235-1244. PubMed ID: 30293617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.
    Waxman AB; McElderry HT; Gomberg-Maitland M; Burke MC; Ross EL; Bersohn MM; Pangarkar SS; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Thompson GB; Torres F; Rauck RL; Clagg K; Durst L; Li P; Morris M; Southall KL; Peterson L; Bourge RC
    Chest; 2017 Dec; 152(6):1128-1134. PubMed ID: 28583617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension.
    Kamp JC; Fuge J; Karsten JF; Rümke S; Hoeper MM; Park DH; Kühn C; Olsson KM
    BMC Pulm Med; 2021 May; 21(1):164. PubMed ID: 33992098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.
    Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C
    J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension.
    Levy M; Del Cerro MJ; Nadaud S; Vadlamudi K; Colgazier E; Fineman J; Bonnet D; Adatia I
    Int J Cardiol; 2018 Aug; 264():153-157. PubMed ID: 29650343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension.
    Richter MJ; Ewert R; Warnke C; Gall H; Classen S; Grimminger F; Mayer E; Seeger W; Ghofrani HA
    Clin Res Cardiol; 2017 Mar; 106(3):174-182. PubMed ID: 27670656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension.
    Skoro-Sajer N; Gerges C; Balint OH; Kohalmi D; Kaldararova M; Simkova I; Jakowitsch J; Gabriel H; Baumgartner H; Gerges M; Sadushi-Kolici R; Celermajer DS; Lang IM
    Heart; 2018 Jul; 104(14):1195-1199. PubMed ID: 29436381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Switch From Subcutaneous to Intravenous Treprostinil in Precapillary Pulmonary Hypertension by Pump Implantation.
    Steringer-Mascherbauer R; Maria L; Reinhold F; Elisabeth S; Charlotte H; Dagmar E; Uwe F; Josef A
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):38-42. PubMed ID: 33079830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.
    Desole S; Velik-Salchner C; Fraedrich G; Ewert R; Kähler CM
    Heart Lung; 2012; 41(6):599-605. PubMed ID: 22920608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.
    Tapson VF; McLaughlin VV; Gomberg-Maitland M; Widlitz AC; Krichman AD; Laliberte KJ; Zaccardelli DS; Barst RJ
    J Vasc Access; 2006; 7(3):112-7. PubMed ID: 17019662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension.
    Dytrych V; Kuchar J; Ambroz D; Kunstyr J; Grus T; Lindner J; Linhart A; Jansa P
    Bratisl Lek Listy; 2020; 121(5):356-361. PubMed ID: 32356433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of treprostinil in the management of pulmonary hypertension.
    Skoro-Sajer N; Lang I
    Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The first LENUS pro® pump implantation in Poland in patient with pulmonary hypertension].
    Pawlak A; Koteja A; Starska A; Kurzyna M; Gil RJ
    Kardiol Pol; 2016; 74(3):300. PubMed ID: 27004544
    [No Abstract]   [Full Text] [Related]  

  • 20. Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension.
    Kimmig LM; Liao C; Bag R
    Lung; 2020 Feb; 198(1):53-58. PubMed ID: 31912412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.